Company Filing History:

4 out of 173

Exelixis, Inc.

1 out of 832,680

Other

patents

Years Active: 2015-2025

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12486233 - Crystalline Solid forms of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of use (2025-12-02),

2. 11760726 - Crystalline solid forms of N-{4-[(6,7-Dimethoxyquinolin-4-yl)oxy]phenyl} -n'-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of use (2023-09-19),

3. 11724986 - Crystalline solid forms of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of use (2023-08-15),

4. 10851061 - Crystalline solid forms of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of use (2020-12-01),

5. 10501418 - Crystalline solid forms of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of use (2019-12-10),

6. 9150571 - Crystalline forms of fused amino pyridines as HSP90 inhibitors (2015-10-06),

Title: The Innovative Contributions of Noel Hamill

Introduction

Noel Hamill is a distinguished inventor based in Belfast, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for cancer treatment. With a total of five patents to his name, Hamill's work is recognized for its potential impact on medical therapies.

Latest Patents

Hamill's latest patents focus on crystalline solid forms of the chemical compound N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide. These inventions relate to novel crystalline solid forms that are useful for the treatment of various types of cancer, including thyroid cancer, prostate cancer, hepatocellular cancer, renal cancer, and non-small cell lung carcinoma. The patents also disclose pharmaceutical compositions comprising these crystalline solid forms, processes for their production, and methods of using them in cancer treatment. Notably, these crystalline solid forms can be utilized to create the L-malate salt of cabozantinib.

Career Highlights

Throughout his career, Noel Hamill has worked with notable companies, including Exelixis, Inc. His experience in the pharmaceutical industry has allowed him to contribute to innovative solutions aimed at improving cancer therapies. His work is characterized by a commitment to advancing medical science through research and development.

Collaborations

Hamill has collaborated with esteemed colleagues, including Dana T Aftab and Nathan Guz. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries in the field of pharmaceuticals.

Conclusion

Noel Hamill's contributions to the field of cancer treatment through his innovative patents and collaborations highlight his role as a significant inventor in the pharmaceutical industry. His work continues to pave the way for advancements in medical therapies that can improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

1 patent pending (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.